The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market During 2026–2030?
The deoxyribonucleic acid (dna) sequencing in drug discovery market size has experienced swift expansion in recent years. It is projected to grow from $8.46 billion in 2025 to $9.49 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.3%. This historical growth can be attributed to several factors, including increasing investment in genomic research, the expansion of pharmaceutical R&D pipelines, the widespread availability of high-throughput sequencing platforms, an escalating focus on personalized medicine, and advancements in sequencing accuracy and speed.
The deoxyribonucleic acid (dna) sequencing in drug discovery market size is projected for significant expansion in the coming years. This market is anticipated to reach $15.22 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.5%. The projected growth during this period stems from factors such as the increasing integration of AI-driven genomic analysis, an elevated demand for targeted therapeutics, the broadening scope of pharmacogenomics applications, a rise in sequencing utilization for early-stage drug screening, and enhanced collaborations between pharmaceutical and biotechnology firms. Prominent trends expected in the forecast period include the increasing deployment of next-generation sequencing for target identification, a growing embrace of single-cell sequencing methodologies, the deeper incorporation of bioinformatics in drug discovery, the expansion of precision medicine research initiatives, and a heightened focus on biomarker-driven drug development.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33087&type=smp
What Key Factors Are Shaping The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market Landscape?
The increasing need for individualized healthcare approaches is projected to stimulate the expansion of deoxyribonucleic acid (DNA) sequencing within the drug discovery market in the future. This medical strategy customizes disease prevention, diagnosis, and treatment based on a person’s unique genetic profile, lifestyle choices, and environmental exposures. The growing interest in personalized medicine largely stems from developments in genomics and molecular diagnostics, facilitating the exact detection of genetic and molecular variations across individuals, thereby enabling treatments to be specifically designed for enhanced efficacy and fewer adverse reactions. Deoxyribonucleic acid (DNA) sequencing supports personalized medicine through the identification of patient-specific genetic differences, which in turn allows for the creation of targeted therapies, refined drug choices, and better treatment outcomes with diminished negative impacts. As an illustration, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit organization, indicated that in 2023, the Food and Drug Administration (FDA) sanctioned 16 novel personalized treatments for rare disease patients, an increase from six in 2022. Among the new personalized treatments approved for 2023 were also seven cancer drugs and three for other diseases and conditions. Consequently, the increasing need for personalized medicine is a key impetus for the expansion of deoxyribonucleic acid (DNA) sequencing within the drug discovery market.
What Are The Key Segment Divisions In The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market Segment Structure?
The deoxyribonucleic acid (dna) sequencing in drug discovery market covered in this report is segmented –
1) By Product Type: Instruments; Consumables
2) By Workflow: Sample Preparation; Sequencing
3) By Technology Type: Sanger Sequencing; Next-Generation Sequencing (NGS)
4) By Application: Drug Discovery; Pharmacogenomics
5) By End-User: Pharmaceutical Companies; Biotechnology Firms
Subsegments:
1) By Instruments: Sequencing Systems; Sample Preparation Systems; Detection And Imaging Systems; Automation And Robotics Systems; Data Analysis Hardware
2) By Consumables: Sequencing Reagents; Library Preparation Kits; Sample Collection Kits; Flow Cells; Quality Control Reagents
What Market Trends Are Affecting The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market?
Major companies engaged in deoxyribonucleic acid (DNA) sequencing within the drug discovery market are prioritizing the development of advanced solutions, including high-resolution DNA methylation sequencing assays, to expedite biomarker discovery and precision drug development. High-resolution DNA methylation sequencing assays are sophisticated genomic methodologies that precisely map DNA methylation at a single-base or near single-base resolution across the entire genome. This allows for an in-depth evaluation of epigenetic changes that govern gene activity, thereby aiding in a precise understanding of disease biology and the identification of prospective drug targets. For example, in April 2025, EpiCypher Inc., a US-based epigenetics company, introduced CUTANA mCUT&RUN and Multiomic CUT&RUN. These two innovative DNA methylation sequencing assays are engineered to provide high-resolution methylation profiling with significantly reduced sequencing costs and minimal sample input. These assays empower researchers to concurrently analyze DNA methylation and chromatin features, delivering profound multiomic insights into gene regulation mechanisms. Such assay innovations facilitate faster and more cost-efficient target identification and validation, consequently accelerating drug discovery and development.
Which Organizations Are Engaged In The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market?
Major companies operating in the deoxyribonucleic acid (dna) sequencing in drug discovery market are Thermo Fisher Scientific Inc., Eurofins Genomics GmbH, Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Genomics, Azenta Life Sciences, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Element Biosciences Inc., Macrogen Inc., Ultima Genomics Inc., SOPHiA GENETICS SA, ProPhase Labs Inc., Singular Genomics Systems Inc., Psomagen Inc., and QitanTech Co Ltd.
Get The Full Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market Report:
Which Region Leads The Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market In Overall Market Size?
North America was the largest region in the deoxyribonucleic acid (DNA) sequencing in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) sequencing in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=33087&type=smp
Browse Through More Reports Similar to the Global Deoxyribonucleic Acid (DNA) Sequencing In Drug Discovery Market 2026, By The Business Research Company
Dna Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Ribonucleic Acid Rna Sequencing Market Report 2026
Clinical Oncology Next Generation Sequencing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model